Skip to main content
. 2022 Aug 17;12:951864. doi: 10.3389/fonc.2022.951864

Figure 2.

Figure 2

Classical mechanisms of ncRNAs in cancer drug resistance. The dysregulation of ncRNAs contributes to the development of cancer drug resistance by modulating multiple cellular processes of cancer cells, such as drug efflux, cell apoptosis, autophagy, and EMT as well as the acquisition of CSC characteristics.